MedPath

Evaluation effect of clemactine after corticosteroid therapy on the reduction of inflammation of the nerve of the eye

Phase 3
Conditions
optic neuritis.
Optic neuritis
Registration Number
IRCT20181124041745N1
Lead Sponsor
Ahvaz University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
30
Inclusion Criteria

Age between 15 and 50 years
Patients with acute optic neuritis symptoms with symptoms beginning at least two weeks before
Use of proper contraception during the study
Signature of consent form

Exclusion Criteria

Other eye diseases (such as diabetic retinopathy, glaucoma, severe myopia, macular degeneration)
Disk hemorrhage
Visual acuity in the absence of light understanding
Cotton wool spots
History of heart conduction block disorders
Suicide history or suicidal thoughts in the last 6 months
Malignancy history
Pregnancy and breast feeding
Serum creatinine higher than 1.5 and liver tests more than twice as normal
History of alcohol consumption over the past year
B12 deficiency or untreated hypothyroidism
Major Diseases of Cardiovascular system, Psychiatric disorders, Metabolic, Hematological and other diseases

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath